De Maria Marchiano, Ruggero
 Distribuzione geografica
Continente #
NA - Nord America 18.007
AS - Asia 12.906
EU - Europa 11.237
SA - Sud America 3.517
AF - Africa 304
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 22
Totale 46.018
Nazione #
US - Stati Uniti d'America 17.642
SG - Singapore 5.389
PL - Polonia 3.483
CN - Cina 3.179
BR - Brasile 2.892
SE - Svezia 1.947
VN - Vietnam 1.590
IT - Italia 1.322
DE - Germania 932
FR - Francia 817
IE - Irlanda 673
ID - Indonesia 508
IN - India 473
GB - Regno Unito 455
FI - Finlandia 359
JP - Giappone 344
RU - Federazione Russa 336
TR - Turchia 302
HK - Hong Kong 277
AR - Argentina 253
UA - Ucraina 208
AT - Austria 205
BD - Bangladesh 157
NL - Olanda 142
MX - Messico 137
IQ - Iraq 136
CA - Canada 128
ZA - Sudafrica 101
EC - Ecuador 96
PK - Pakistan 68
VE - Venezuela 65
CO - Colombia 59
SA - Arabia Saudita 59
ES - Italia 58
PY - Paraguay 52
MY - Malesia 46
MA - Marocco 44
BE - Belgio 42
KR - Corea 42
CH - Svizzera 40
UZ - Uzbekistan 36
PE - Perù 31
KE - Kenya 30
JO - Giordania 29
PH - Filippine 29
IR - Iran 28
RO - Romania 28
EG - Egitto 27
CL - Cile 26
DZ - Algeria 26
AE - Emirati Arabi Uniti 24
AZ - Azerbaigian 22
UY - Uruguay 21
LT - Lituania 20
AU - Australia 19
KZ - Kazakistan 19
NP - Nepal 19
BG - Bulgaria 17
CZ - Repubblica Ceca 17
OM - Oman 17
AL - Albania 16
IL - Israele 16
BO - Bolivia 15
JM - Giamaica 15
PA - Panama 15
DO - Repubblica Dominicana 14
GE - Georgia 14
PT - Portogallo 14
CR - Costa Rica 13
TN - Tunisia 13
BY - Bielorussia 12
CI - Costa d'Avorio 12
ET - Etiopia 12
HN - Honduras 11
NO - Norvegia 11
RS - Serbia 11
TW - Taiwan 11
EU - Europa 10
LB - Libano 10
LV - Lettonia 10
BH - Bahrain 9
PS - Palestinian Territory 9
TH - Thailandia 9
HU - Ungheria 8
SN - Senegal 8
TT - Trinidad e Tobago 8
GA - Gabon 7
GR - Grecia 7
LK - Sri Lanka 7
LU - Lussemburgo 7
SK - Slovacchia (Repubblica Slovacca) 7
XK - ???statistics.table.value.countryCode.XK??? 7
AM - Armenia 6
BA - Bosnia-Erzegovina 6
BB - Barbados 6
EE - Estonia 6
AO - Angola 5
HR - Croazia 5
KH - Cambogia 5
MD - Moldavia 5
Totale 45.935
Città #
Warsaw 3.444
Singapore 2.461
Ashburn 1.656
Chandler 1.640
Fairfield 1.488
San Jose 1.386
Redmond 767
Wilmington 731
Woodbridge 694
Houston 688
Beijing 674
Dublin 672
Seattle 657
Cambridge 508
Ho Chi Minh City 490
Nanjing 487
Jakarta 425
Lauterbourg 367
Princeton 346
Ann Arbor 336
Hanoi 324
Boston 317
Hangzhou 316
Tokyo 297
Helsinki 277
Hong Kong 259
Los Angeles 253
San Mateo 249
New York 248
Council Bluffs 245
Dong Ket 242
São Paulo 242
Rome 239
Jacksonville 208
Izmir 207
Dearborn 206
Chicago 200
Frankfurt am Main 198
Cattolica 194
Nanchang 181
Vienna 177
Moscow 173
Dallas 165
Milan 149
Munich 142
London 117
The Dalles 98
Shenyang 97
Hyderabad 92
Rio de Janeiro 91
Santa Clara 87
San Diego 86
Tianjin 80
Nuremberg 77
Phoenix 77
Bremen 75
Norwalk 75
Hebei 72
Orem 72
Belo Horizonte 70
Kunming 70
Redwood City 70
Curitiba 62
Düsseldorf 62
Mountain View 62
Shanghai 61
Brooklyn 58
Buffalo 58
Paris 57
Hefei 56
Marseille 56
Da Nang 53
Jiaxing 53
Baghdad 51
Haiphong 50
Brasília 49
Falkenstein 48
Guangzhou 48
Chennai 47
Changsha 45
Denver 44
Johannesburg 43
Brussels 41
Campinas 41
Montreal 41
Porto Alegre 38
San Francisco 36
Atlanta 35
Mexico City 34
Tashkent 34
Goiânia 33
Kuala Selangor 33
Amsterdam 31
Biên Hòa 31
Lappeenranta 31
Quito 31
Stockholm 31
Andover 30
Boardman 30
Buenos Aires 30
Totale 28.705
Nome #
CHK1-targeted therapy to deplete DNA replication- stressed, p53-deficient, hyperdiploid colorectal cancer stem cells 436
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes 395
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer 385
Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations 370
The Hippo pathway in normal development and cancer 358
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 340
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real- world experience 337
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 327
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 325
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 325
Two-Step Co-Immunoprecipitation (TIP) Enables Efficient and Highly Selective Isolation of Native Protein-Complexes. 307
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 304
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes with Different Clinical Outcome 299
Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis 299
Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications 299
(1)H NMR detects different metabolic profiles in glioblastoma stem-like cells 294
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies 293
Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer 293
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 291
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells. 289
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer 288
miR-663 sustains NSCLC by inhibiting mitochondrial outer membrane permeabilization (MOMP) through PUMA/ BBC3 and BTG2 287
Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance 286
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer 285
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 280
Alliance Against Cancer, the network of Italian cancer centers bridging research and care 279
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 278
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer 278
Protein drug target activation homogeneity in the face of intra- tumor heterogeneity: implications for precision medicine 277
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 277
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer 277
A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology 276
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal 272
Replication stress in colorectal cancer stem cells 272
Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study 271
Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy 268
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B 262
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 258
The autophagic protein FYCO1 controls TNFRSF10/TRAIL receptor induced apoptosis and is inactivated by CASP8 (caspase 8) 257
Colorectal cancer: towards new challenges and concepts of preventive healthcare 256
Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer 254
Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression 254
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 253
Gene Expression Analysis of PTEN Positive Glioblastoma Stem Cells Identifies DUB3 and Wee1 Modulation in a Cell Differentiation Model 247
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 245
Analysis of the ATR-Chk1 and ATM- Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression 241
HMG-CoAR expression in male breast cancer: Relationship with hormone receptors, Hippo transducers and survival outcomes 236
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 232
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 227
DNA damage and repair biomarkers in cervical cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis 225
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 221
Integrin a7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 210
A BMP7 variant inhibits tumor angiogenesis in vitro and in vivo through direct modulation of endothelial cell biology 210
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant 209
A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer 206
1H NMR spectroscopy of glioblastoma stem‐like cells identifies alpha‐aminoadipate as a marker of tumor aggressiveness 203
Exploiting bioactive natural products of marine origin: Evaluation of the meroterpenoid metachromin V as a novel potential therapeutic drug for colorectal cancer 200
A real-time integrated framework to support clinical decision making for covid-19 patients 197
Antisense RNA for Treating Cancer and Inhibition of Metastasis and Vectors for Antisense Sequestration 189
Essential versus accessory aspects of cell death: Recommendations of the NCCD 2015 186
Inhibitor of integrin for the treatment or prevention of tumours 185
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin 183
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 180
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells 177
“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome 169
The targeting of mre11 or rad51 sensitizes colorectal cancer stem cells to chk1 inhibition 167
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 167
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 163
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis. 160
C-Met/MIR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 156
Two-Step Co-Immunoprecipitation (TIP) 156
Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51 155
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome 153
Blocking the APRIL circuit enhances acute myeloid leukemia cell chemosensitivity 153
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 150
Alliance Against Cancer, the network of Italian cancer centers bridging research and care 146
Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression 144
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 142
Two-Step Coimmunoprecipitation (TIP) enables efficient and highly selective isolation of native protein complexes 142
"Triple positive" early breast cancer: An observational multicenter retrospective analysis of outcome 140
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 140
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 139
Antitumor effect of miR-197 targeting in p53 wild-type lung cancer 138
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 138
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 136
The inhibition of the highly expressed mir-221 and mir-222 impairs the growth of prostate carcinoma xenografts in mice 135
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 135
Cancer stem cell-based models of colorectal cancer reveal molecular determinants of therapy resistance 134
Nobiletin and xanthohumol sensitize colorectal cancer stem cells to standard chemotherapy 134
13C-Urea breath test for the diagnosis of Helicobacter pylori infection. 132
1H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness 132
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 130
CD147 Promotes Cell Small Extracellular Vesicles Release during Colon Cancer Stem Cells Differentiation and Triggers Cellular Changes in Recipient Cells 130
Gene expression analysis of PTEN positive glioblastoma stem cells identifies DUB3 and Wee1 modulation in a cell differentiation model 129
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer 129
Replication stress in colorectal cancer stem cells 128
Epithelial-mesenchymal transition: a new target in anticancer drug discovery 127
Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous Venture 127
Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer 127
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 126
Totale 22.329
Categoria #
all - tutte 195.482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 195.482


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021675 0 0 0 0 0 0 0 0 0 217 171 287
2021/20222.817 262 265 127 133 164 145 72 419 134 125 481 490
2022/20235.168 766 704 469 554 375 648 112 454 671 125 201 89
2023/20242.747 102 918 86 132 115 221 204 83 31 84 345 426
2024/20256.514 225 123 486 228 371 347 227 401 968 768 1.380 990
2025/202615.393 2.499 650 1.387 2.262 2.320 709 2.627 696 1.010 1.233 0 0
Totale 46.665